Technology
becomes Opportunity

Medical Device Innovation
for the Heart

Breakthrough, cost-effective solutions for diseases affecting heart valves

Rheumatic Heart Disease (RHD) is a potentially deadly but preventable disease affecting at least 40 million people around the world – mostly in developing countries. Once patients become symptomatic, open-heart surgery is currently the only treatment. In developing countries, this is usually not feasible from a medical infrastructure, medical skills or cost perspective.


Strait Access Technologies’ (SAT) innovative RHD medical solutions eliminate this requirement for open-heart surgery. SAT’s heart valves are suited for younger RHD patients in whom conventional heart valve prostheses often degenerate rapidly.


SAT technology offers cost-effective and minimally-invasive transcatheter heart therapies, allowing RHD patients to undergo life-saving treatment where there is currently no alternative option.


READ MORE ABOUT SAT'S STORY

Making a Difference

SAT is redefining the treatment of heart valve diseases. As a world-first, we create durable transcatheter aortic valves specifically developed for Rheumatic Heart Disease (RHD), but also suited to Degenerative Heart Disease (DHD).

READ MORE ABOUT OUR PATIENTS

Expanding the Frontiers

Innovative, Affordable and Durable Solutions

Tavr Systems

Beyond the established –
without skipping a beat

Transcatheter
Mitral
Valve
Repair

Addressing complexity
through simplicity

Reducing Complexity

Carrying the ease of Frontier-Solutions into established procedures